Zafgen, Inc. (ZFGN)

2.51
0.13 5.46
NASDAQ
Prev Close 2.38
Open 2.39
Day Low/High 2.38 / 2.52
52 Wk Low/High 4.10 / 12.36
Volume 69.75K
Exchange NASDAQ
Shares Outstanding 37.31B
Market Cap 91.42M
Div & Yield N.A. (N.A)

Latest News

Zafgen Becomes Oversold (ZFGN)

Zafgen Becomes Oversold (ZFGN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

CURRENT SHAREHOLDERS: Zamansky LLC Investigates Zafgen (ZFGN) For Potential Breaches Of Fiduciary Duties

CURRENT SHAREHOLDERS: Zamansky LLC Investigates Zafgen (ZFGN) For Potential Breaches Of Fiduciary Duties

Zamansky LLC announces that it is investigating Zafgen, Inc. (NASDAQ:ZFGN) ("Zafgen" or the "Company") for potential breaches of fiduciary duties by its officers and board of directors.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Zafgen, Inc. - ZFGN

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Zafgen, Inc. - ZFGN

NEW YORK, Nov. 28, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zafgen, Inc.

Zafgen Becomes Oversold (ZFGN)

Zafgen Becomes Oversold (ZFGN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting ZFGN Put Options For September 21st

Interesting ZFGN Put Options For September 21st

Investors in Zafgen Inc saw new options begin trading this week, for the September 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ZFGN options chain for the new September 21st contracts and identified the following put contract of particular interest.

Zafgen Becomes Oversold (ZFGN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Zafgen Initiates Phase 2 Clinical Trial For ZGN-1061 In Patients With Type 2 Diabetes

Zafgen Initiates Phase 2 Clinical Trial For ZGN-1061 In Patients With Type 2 Diabetes

-Company Expects to Report Interim Data from ZAF-1061-201 in First Half of 2018-

Zafgen Rebounds With a Safer Obesity Drug Targeting Diabetics

Zafgen Rebounds With a Safer Obesity Drug Targeting Diabetics

Zafgen is disclosing Thursday evening the first human data on ZGN-1061, with plans to move the obesity drug into a phase II study.

Zafgen Reaches Analyst Target Price

In recent trading, shares of Zafgen Inc have crossed above the average analyst 12-month target price of $5.00, changing hands for $5.01/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

The Setup Is Good for a Bounce, but it Hasn't Happened Yet

The Setup Is Good for a Bounce, but it Hasn't Happened Yet

Some small names are interesting, but more-aggressive position trades are not developing right now.

Zafgen Reports Fourth Quarter And Full Year 2016 Financial Results

On Track to Complete Dosing of Phase 1 Clinical Trial for ZGN-1061 by the End of the First Quarter of 2017